Trial Profile

A phase IIa trial is a multi-center, randomized, double-blind, placebo-controlled study to evaluate the use of Tetramethylpyrazine Nitrone tablets in the treatment of subjects with early diabetic kidney disease

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 23 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Jun 2022 Results presented at the 82nd Annual Scientific Sessions of the American Diabetes Association
07 Jul 2021 Status changed from recruiting to active, no longer recruiting, according to a Guangzhou Magpie Pharmaceuticals media release.
07 Jul 2021 Status changed from planning to recruiting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com